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Abstract 
Background and Objective: Telomerase is in charge of telomere extending. It is triggered in 
about 90% of cancer cells. hTERT is the controlling subunit of telomerase and plays a critical 
role in the activation of telomerase. The mechanism through which hTERT regulate the invasion 
and metastasis of cancer is unclear. miRNAs are the novel regulator of gene silencing and can 
target hTERT by binding the 3’ UTR of its mRNA, and regulate gene expression. In the previous 
study reported that miR-1266 can target hTERT in gastric (SGC-7901) cancer. In this study, we 
have made the first report of miR-1266-5p role on the hTERT expression, its various transcripts, 
telomerase activity, and biological functions, including cell proliferation and cell cycle in AGS, 
MCF7, A375, and HepG2 cells. 
Methods: For investigating the function of miR-1266-5p, we used chemically synthesized 
oligonucleotide mimics and inhibitors. AGS, MCF7, A375, and HepG2 cells were transfected 
with miR-1266-5p mimic, inhibitor, and just HiperFect reagent as a negative control. The 
Expression levels of miR-1266-5p, hTERT, its variant transcripts, and transfection efficiency 
were analyzed by Taqman qRT-PCR. The cell proliferation and cell cycle changes were detected 
by MTT calorimetric assay and flow cytometry, respectively. Also, Quantitative TRAP Assay 
was used to detect telomerase activity. 
Results: The results showed that the expression of miR-1266-5p significantly was increased 
after transfection by mimic compared to control cells, while its expression was decreased in 
transfected cells by the inhibitor. Also, we confirmed that upregulated miR-1266-5p significantly 
decreased cell growth, although inhibitor promoted cell proliferation. This finding was 
confirmed by cell cycle analysis, as upregulation of miR-1266-5p induced cells cycle arrest at 
the transition of G1 to S phase and led to G0/G1 entry, while the downregulation of miR-1266-
5p promoted cell growth and led to G2/M entry. Concordantly, the overexpression of miR-1266-
5p resulted in down-regulated hTERT expression and also suppressed telomerase activity. Also, 
upregulation of miR-1266-5p decreased full-length variant and increased alpha variant compared 
to transfected cells by inhibitor and control cells. 
Conclusion: our results demonstrated that miR-1266-5p can target hTERT expression and 
telomerase activity in the Gastric (AGS), Breast (MCF7), Liver (HepG2), and Melanoma (A375) 
cancer cell lines, so acts as hTERT and telomerase activity suppressor. miR-1266-5p could also 
decrease cell proliferation and induce cell cycle arrest, while its inhibition eliminates miR-1266-
5p effects. In addition, miR-1266-5p can affect hTERT variants in AGS cell line and alter their 
expression as well as result in downregulate of hTERT expression. Thus, upregulation of miR-
1266-5p may be a serve as a novel therapeutic target in AGS, MCF7, A375, HepG2 cell lines. 
Thus, delivery of miR-1266-5p to these cells can be an effective therapeutic target for the 
treatment of Gastric, Breast, Liver, and Melanoma cancers. 
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